152 related articles for article (PubMed ID: 34294609)
1. Endoplasmic Reticulum Stress Induces CAP2 Expression Promoting Epithelial-Mesenchymal Transition in Liver Cancer Cells.
Yoon S; Shin B; Woo HG
Mol Cells; 2021 Aug; 44(8):569-579. PubMed ID: 34294609
[No Abstract] [Full Text] [Related]
2. Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression.
Effendi K; Yamazaki K; Mori T; Masugi Y; Makino S; Sakamoto M
Exp Cell Res; 2013 Jan; 319(1):35-44. PubMed ID: 23022774
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
[TBL] [Abstract][Full Text] [Related]
4. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.
Zhang G; Gao Z; Guo X; Ma R; Wang X; Zhou P; Li C; Tang Z; Zhao R; Gao P
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37707957
[TBL] [Abstract][Full Text] [Related]
5. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
[TBL] [Abstract][Full Text] [Related]
6. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.
Liu SH; Lee WJ; Lai DW; Wu SM; Liu CY; Tien HR; Chiu CS; Peng YC; Jan YJ; Chao TH; Pan HC; Sheu ML
Mol Oncol; 2015 Apr; 9(4):834-49. PubMed ID: 25619450
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
8. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
[TBL] [Abstract][Full Text] [Related]
9. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis.
Shibata R; Mori T; Du W; Chuma M; Gotoh M; Shimazu M; Ueda M; Hirohashi S; Sakamoto M
Clin Cancer Res; 2006 Sep; 12(18):5363-8. PubMed ID: 17000669
[TBL] [Abstract][Full Text] [Related]
11. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
13. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
14. Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.
Akhtar N; Syed DN; Lall RK; Mirza B; Mukhtar H
Mol Carcinog; 2018 May; 57(5):653-663. PubMed ID: 29436741
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K
Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477
[TBL] [Abstract][Full Text] [Related]
16. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
17. NEIL3 promotes hepatoma epithelial-mesenchymal transition by activating the BRAF/MEK/ERK/TWIST signaling pathway.
Lai HH; Hung LY; Yen CJ; Hung HC; Chen RY; Ku YC; Lo HT; Tsai HW; Lee YP; Yang TH; Chen YY; Huang YS; Huang W
J Pathol; 2022 Dec; 258(4):339-352. PubMed ID: 36181299
[TBL] [Abstract][Full Text] [Related]
18. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
